Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In episode 2 of 4, we’ll discuss:

• How do you prepare your team and the patient for a switch to a biosimilar?

• Are there any situations where switching is not appropriate?

• What do you think about multiple switches?

• How do you minimize the potential for a nocebo effect?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.